Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Petrobras
PBR
$125B
| $51.6M | 0.09% |
3,444,500
-658,700
| -16% | -$9.37M |
|
252
BioMarin Pharmaceuticals
BMRN
$11.6B
| $51.5M | 0.09% |
581,771
-150,867
| -21% | -$13.4M |
|
253
argenx
ARGX
$54.6B
| $51.5M | 0.09% |
104,700
-9,300
| -8% | -$4.55M |
|
254
Travelers Companies
TRV
$78.1B
| $51.5M | 0.09% |
315,172
+211,700
| +205% | +$35.4M |
|
|
SWAV
255
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $51.1M | 0.09% |
256,600
+53,800
| +27% | +$12.7M |
|
256
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
| $50.6M | 0.09% |
505,400
+182,000
| +56% | +$18.2M |
|
257
iShares Treasury Floating Rate Bond ETF
TFLO
$6.54B
| $50.5M | 0.09% |
995,900
+301,100
| +43% | +$15.2M |
|
258
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.64B
| $50.5M | 0.09% |
504,200
+153,600
| +44% | +$15.3M |
|
259
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
| $50.5M | 0.09% |
456,900
+139,800
| +44% | +$15.4M |
|
260
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.07B
| $50.5M | 0.09% |
1,001,800
+341,500
| +52% | +$17.2M |
|
261
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.4B
| $50.5M | 0.09% |
501,300
+153,900
| +44% | +$15.5M |
|
262
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
| $50.5M | 0.09% |
549,600
+166,900
| +44% | +$15.3M |
|
263
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
| $50.4M | 0.09% |
1,005,200
+364,800
| +57% | +$18.3M |
|
264
PGIM Ultra Short Bond ETF
PULS
$17.7B
| $50.4M | 0.09% |
1,018,300
+367,500
| +56% | +$18.1M |
|
265
Crown Castle
CCI
$33.3B
| $50.3M | 0.09% |
546,603
+310,500
| +132% | +$32.2M |
|
266
WisdomTree Floating Rate Treasury Fund
USFR
$18.1B
| $50.2M | 0.09% |
997,900
+302,200
| +43% | +$15.2M |
|
267
First Trust Enhanced Short Maturity ETF
FTSM
$6.49B
| $50.2M | 0.09% |
844,300
+256,700
| +44% | +$15.3M |
|
268
Snap-on
SNA
$21.2B
| $50.1M | 0.09% |
196,300
+11,600
| +6% | +$3.13M |
|
269
Nutanix
NTNX
$16B
| $50M | 0.09% |
1,434,393
-298,207
| -17% | -$9.36M |
|
270
Takeda Pharmaceutical
TAK
$54.6B
| $50M | 0.09% |
3,230,900
-419,100
| -11% | -$6.49M |
|
271
IonQ
IONQ
$13.6B
| $49.9M | 0.09% |
3,356,400
+1,224,500
| +57% | +$19.2M |
|
272
iShares Short Maturity Bond ETF
NEAR
$4.83B
| $49.7M | 0.08% |
996,700
+350,100
| +54% | +$17.4M |
|
273
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.89B
| $49.5M | 0.08% |
498,100
+173,600
| +53% | +$17.2M |
|
274
Pacira BioSciences
PCRX
$1.04B
| $49.5M | 0.08% |
1,613,997
+39,300
| +2% | +$1.42M |
|
275
Sturm, Ruger & Co
RGR
$594M
| $49.4M | 0.08% |
948,276
+16,900
| +2% | +$888K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.